This Article Full Text Full Text (PDF) All Versions of this Article: 111/2/173    most recent 01.CIR.0000151612.02223.F2v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rongen, G. A. Articles by Smits, P. Search for Related Content PubMed PubMed Citation Articles by Rongen, G. A. Articles by Smits, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PHENTOLAMINE Related Collections Ischemic biology - basic studies Related Article

(Circulation. 2005;111:173-178.)
© 2005 American Heart Association, Inc.

Heart Failure

Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans

Gerard A. Rongen, MD, PhD; Wim J.G. Oyen, MD, PhD; Bart P. Ramakers, MSc; Niels P. Riksen, MD; Otto C. Boerman, PhD; Neil Steinmetz, MD; Paul Smits, MD, PhD

From the Departments of Pharmacology-Toxicology (G.A.R., B.P.R., N.P.R., P.S.), Nuclear Medicine (W.J.G.O., O.C.B.), and Internal Medicine (G.A.R., N.P.R., P.S.), Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands, and Theseus Imaging Corporation (N.S.), Boston, Mass.

Correspondence to G.A. Rongen, MD, PhD, Department of Pharmacology-Toxicology, Radboud University Nijmegen Medical Center, Nijmegen, Geert Grooteplein 21, PO Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail G.Rongen{at}pharmtox.umcn.nl

Received July 19, 2004; revision received August 31, 2004; accepted September 14, 2004.

Background— Nonlethal ischemia and reperfusion reduce ischemia-reperfusion-induced cell death, a phenomenon called ischemic preconditioning. In animal models, this potent endogenous protection is mimicked in vivo by administration of adenosine. In humans, exploitation of ischemic preconditioning is hindered by the lack of an appropriate in vivo model to study this phenomenon. To solve this problem, we aimed to set up an easy-to-use human in vivo model to study ischemic or pharmacological preconditioning.

Methods and Results— Healthy male volunteers performed unilateral ischemic handgrip. At reperfusion, we intravenously injected technetium-99m-labeled Annexin A5, a presumed marker of ischemic injury, and we imaged both forearms and hands simultaneously with a gamma camera. Region of interest analysis (counts per pixel) and subsequent calculation of the percentage difference in radioactivity between experimental and control hands (thenar muscle; mean±SE) revealed significant uptake to the ischemically exercised tissue (26±3% at 4 hours after reperfusion; P<0.05). This selective localization of Annexin A5 was reduced by ischemic preconditioning (10 minutes of ischemia plus reperfusion before ischemic exercise) or by infusion of adenosine into the brachial artery to 6±1% and 10±3%, respectively (P<0.05 versus ischemic exercise alone), resembling observations in animal models with infarct size as an end point. Appropriate control experiments supported our conclusion.

Conclusions— Annexin A5 scintigraphy can be applied to test pharmacological or physiological interventions for their ability to prevent ischemia-reperfusion injury.

Key Words: adenosine • exercise • ischemia • scintigraphy

Related Article:

We Think We See a Pattern Emerging Here

James M. Downey and Michael V. Cohen
Circulation 2005 111: 120-121. [Full Text]

This article has been cited by other articles:

				F. G. Blankenberg In Vivo Detection of Apoptosis J. Nucl. Med., June 1, 2008; 49(Suppl_2): 81S - 95S. [Abstract] [Full Text] [PDF]

				N. P. Riksen, B. Franke, W. J.G. Oyen, G. F. Borm, P. van den Broek, O. C. Boerman, P. Smits, and G. A. Rongen Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene Eur. Heart J., May 1, 2007; 28(9): 1085 - 1091. [Abstract] [Full Text] [PDF]

				N. P. Riksen, Z. Zhou, W. J.G. Oyen, R. Jaspers, B. P. Ramakers, R. M.H.J. Brouwer, O. C. Boerman, N. Steinmetz, P. Smits, and G. A. Rongen Caffeine Prevents Protection in Two Human Models of Ischemic Preconditioning J. Am. Coll. Cardiol., August 15, 2006; 48(4): 700 - 707. [Abstract] [Full Text] [PDF]

				J. M. Downey and M. V. Cohen We Think We See a Pattern Emerging Here Circulation, January 18, 2005; 111(2): 120 - 121. [Full Text] [PDF]